Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Total Liabilities
Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has total liabilities worth Rs461.88 Million INR (≈ $5.00 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) cash flow conversion to assess how effectively this company generates cash.
Jagsonpal Pharmaceuticals Limited - Total Liabilities Trend (2006–2025)
This chart illustrates how Jagsonpal Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Jagsonpal Pharmaceuticals Limited to evaluate the company's liquid asset resilience ratio.
Jagsonpal Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Jagsonpal Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
msg life ag
HM:MSGL
|
Germany | €36.56 Million |
|
Condor Energies Inc.
TO:CDR
|
Canada | CA$76.61 Million |
|
Huangshan Tourism Development Co Ltd B
SHG:900942
|
China | $878.19 Million |
|
Global Lighting Technologies Inc
TW:4935
|
Taiwan | NT$2.25 Billion |
|
Prospect Resources Ltd
AU:PSC
|
Australia | AU$2.30 Million |
|
Aroa Biosurgery Ltd
AU:ARX
|
Australia | AU$14.34 Million |
|
GOLFZON NEWDIN HOLDINGS Co. Ltd
KQ:121440
|
Korea | ₩336.06 Billion |
|
Seritage Growth Properties
NYSE:SRG
|
USA | $219.52 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Jagsonpal Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jagsonpal Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jagsonpal Pharmaceuticals Limited (2006–2025)
The table below shows the annual total liabilities of Jagsonpal Pharmaceuticals Limited from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs383.10 Million ≈ $4.14 Million |
+29.09% |
| 2024-03-31 | Rs296.76 Million ≈ $3.21 Million |
-17.70% |
| 2023-03-31 | Rs360.56 Million ≈ $3.90 Million |
-4.10% |
| 2022-03-31 | Rs375.99 Million ≈ $4.07 Million |
-11.06% |
| 2021-03-31 | Rs422.73 Million ≈ $4.57 Million |
+17.68% |
| 2020-03-31 | Rs359.21 Million ≈ $3.88 Million |
+14.72% |
| 2019-03-31 | Rs313.11 Million ≈ $3.39 Million |
-1.44% |
| 2018-03-31 | Rs317.68 Million ≈ $3.44 Million |
-2.84% |
| 2017-03-31 | Rs326.97 Million ≈ $3.54 Million |
-46.32% |
| 2016-03-31 | Rs609.17 Million ≈ $6.59 Million |
+3.61% |
| 2015-03-31 | Rs587.94 Million ≈ $6.36 Million |
+1.95% |
| 2014-03-31 | Rs576.68 Million ≈ $6.24 Million |
+5.56% |
| 2013-03-31 | Rs546.30 Million ≈ $5.91 Million |
-5.21% |
| 2012-03-31 | Rs576.30 Million ≈ $6.23 Million |
+31.56% |
| 2011-03-31 | Rs438.04 Million ≈ $4.74 Million |
+22.81% |
| 2010-03-31 | Rs356.69 Million ≈ $3.86 Million |
-16.29% |
| 2009-03-31 | Rs426.09 Million ≈ $4.61 Million |
-22.84% |
| 2008-03-31 | Rs552.21 Million ≈ $5.97 Million |
-26.36% |
| 2007-03-31 | Rs749.83 Million ≈ $8.11 Million |
+5.14% |
| 2006-03-31 | Rs713.18 Million ≈ $7.71 Million |
-- |
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. … Read more